Neurocrine Biosciences NBIX
NASDAQ NBIX
$141.84 +3.49 (+2.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Operating Expenses (2010 - 2026)

Updated

Neurocrine Biosciences (NBIX) reported Operating Expenses of $807.5 million for Q2 2026, up 49.0% from $541.9 million a year earlier and up 30.0% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Operating Expenses came in at $2.58 billion, up 28.0% year-over-year; for FY2025, it was $2.24 billion, up 25.6% from FY2024.

  • Operating Expenses has increased for 14 consecutive years, with a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $1.78 billion in FY2024 (+9.1%), $1.64 billion in FY2023 (+32.0%), $1.24 billion in FY2022 (+20.2%) and $1.03 billion in FY2021 (+16.8%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q2 2010.
  • Year over year, Operating Expenses has now increased in each of the last nine quarters, with growth averaging 27.6% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q4 2021 (growth of 97.8%); the low point was Q1 2024 (a decline of 22.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $621.1 million (Q1 2026), $594.6 million (Q4 2025) and $555.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Neurocrine Biosciences 14.41 Bn 10.11 Bn 935.80 Mn 807.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 807.50 Mn
Mar 31, 2026 621.10 Mn
Dec 31, 2025 594.60 Mn
Sep 30, 2025 555.90 Mn
Jun 30, 2025 541.90 Mn
Mar 31, 2025 549.00 Mn
Dec 31, 2024 485.70 Mn
Sep 30, 2024 438.30 Mn
Jun 30, 2024 444.80 Mn
Mar 31, 2024 416.00 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 357.60 Mn
Jun 30, 2023 379.10 Mn
Mar 31, 2023 534.60 Mn
Dec 31, 2022 308.60 Mn
Sep 30, 2022 300.10 Mn
Jun 30, 2022 323.50 Mn
Mar 31, 2022 307.50 Mn
Dec 31, 2021 348.30 Mn
Sep 30, 2021 251.50 Mn
API Access

Neurocrine Biosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEY